OUR BUY SIGNAL IN THE FACE OF MULTIPLE DOWNGRADES BY THE WALL STREET ON $BSX (BOSTON SCIENTIFIC) HAS PROVEN TO BE THE CORRECT CALL
On March 15,2010 when Boston Scientific’s defibrillators were taken off the market, the Wall Street uniformly issued downgrades. Goldman Sachs downgraded to Conviction Sell.: JP Morgan said sell, Barron’s urged investors to sell and the sell chorus chimed throughout the Wall Street. More specifically, several Gurus pronounced that the products would not return to the market for several months.
… Please click here or the title below to read more. In the face of the Wall Street’s unanimous selling calls, we issues a buy signal — the fact that we were familiar with the manufacturing process added conviction to our call. More specifically, our analysis showed that the infractions were minor paperwork infractions and our best estimate was that the products may return to the market in as few as 30 days.
April 18, 2010